Chose & Order your EUA approved Covid-19 Rapid test 

Serology Antibody Testing

EUA by FDA approved 

  • These test have been authorized by FDA under an EUA for use by authorized laboratories;

  • These test have been authorized only for the presence of lgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;

  • These Emergency Use Authorization – In Vitro Diagnostic Use Only)

  • Not for screening of donated blood

  • IgM antibodies begin to show up in a patient’s blood roughly 5-7 days after infection and indicate an active infection.  IgG antibodies develop anywhere from 9-14 days after infection and indicate convalescence or a past infection.

antibodytest.jpg

FDA website link regarding EUA Tests

Pre-Screening
EUA by FDA Approved
$1 OFF 
First Order
Larger then 5,000 units

Biohit Test Kit 

Screenshot 2020-06-27 at 8.32.08 PM.png
ANTIBODY

  • The accuracy in total is 99.01% for the COVID-19 IgG/IgM rapid test cassette 

  • FDA Emergency Use Authorization (EUA)

  • Rapid results within 15 minutes

  • Sold in packs of 25

  • Shelf life of up to 24 months from manufacture date

  • Verification of us is mandatory prior to shipping

  • 3 Clinical Studies 

  • Test to be performed in a CLIA moderate- or high-complexity setting

ANTIGEN TEST
How to Read Test
Screenshot 2020-06-27 at 8.39.19 PM.png
             InBios
CLIA Waiver & EUA/FDA Approved
  • CLIA Waived

  • The accuracy in total is 97.7% for the COVID-19 IgG/IgM rapid test cassette 

  • FDA Emergency Use Authorization (EUA)

  • Rapid results within 15 minutes

  • Sold in packs of 20

  • Shelf life of up to 24 months from manufacture date

  • Verification of us is mandatory prior to shipping

  • Test to be performed in a CLIA moderate- or high-complexity setting

ANTIGEN TEST
ANTIGEN TRUST 

CareStart Antigen Test

CLIA Waived & EUA/FDA Approved
  • CLIA Waived

  • Rapid results in 10 minutes

  • Minimally invasive specimen collection

  • (nasopharyngeal)

  • Intended at POC setting (i.e., in patient care

  • settings) by medical professionals

  • Detect SARS-CoV-2 nucleocapsid protein antigen

  • Identify acute infection with high sensitivity and 100% specificity

Celltrion DiaTrust
EUA by FDA Approved
  • FDA Emergency Use Authorization (EUA)

  • Rapid results within 10-15 minutes

  • Sold in packs of 20

  • Shelf life of up to 24 months from manufacture date

  • Test to be performed in a CLIA moderate- or high-complexity setting 

  • Published Stanford University study

  • Clinical trials completed with LA County/USC, UNLV

  • The accuracy Sensitivity 93.33% Specificity 99.03%

  • Strong USA based supporting clinical data and exposure LA County USC Media Stanford Test Media

  • Strong base of large commercial clients such as; MLB Buys Premier